Compare Ginkgo Bioworks Holdings Inc (DNA) vs Ecopetrol SA (EC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Ecopetrol SA — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9 (market cap $590.53M), while Ecopetrol SA trades at $16.03 (market cap $29.46B). The key difference: Ecopetrol SA is far larger — about 49.9× Ginkgo Bioworks Holdings Inc's market cap, and Ecopetrol SA pays a 4.02% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | EC | |
|---|---|---|
Market Cap | $590.53M | $29.46B |
Sector | Health | Energy |
52-Week High | $16.14 | $16.58 |
52-Week Low | $5.48 | $8.29 |
Enterprise Value | $627.78M | $57.24B |
Dividend Yield | — | 4.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
Ecopetrol (EC) trades at $15.88, up 1.93% with a bullish technical signal from moving averages. The stock shows mixed earnings performance with recent misses but maintains solid profitability with 8.76% net margin and 13.01% ROE. Recent positive developments include a collective bargaining agreement with workers and S&P credit rating affirmation. Valuation appears reasonable with P/E of 11.31 and P/S of 0.99, trading near analyst consensus target of $14.63.
EC presents a balanced opportunity with attractive valuation metrics and stable dividend yield, though facing revenue decline from $159.6B in 2022 to $119.7B in 2025. Key risks include ongoing revenue pressure, debt levels at 42.51% of assets, and oil price volatility. Analyst sentiment is cautious with 27% buy ratings versus 55% hold, suggesting limited near-term upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →
